دورية أكاديمية

4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion.

التفاصيل البيبلوغرافية
العنوان: 4CMenB Vaccination to Prevent Meningococcal B Disease in Vietnam: Expert Review and Opinion.
المؤلفون: Nguyen PNT; Pediatrics Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Thai PQ; Communicable Diseases Control and Prevention Department, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam., Dien TM; National Pediatric Hospital, Hanoi, Vietnam., Hai DT; Center for Tropical Diseases, National Pediatric Hospital, Hanoi, Vietnam., Dai VTT; Respiratory Microbiology Bacteria Laboratory, Department of Immunology and Microbiology, the Pasteur Institute in Ho Chi Minh City, Ho Chi Minh City, Vietnam., Luan NH; Immunization Unit of University of Medicine and Pharmacy Hospital, Pediatrics Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Mathur G; GSK, Ho Chi Minh City, Vietnam., Badur S; GSK, Istanbul, Turkey., Truyen DM; GSK, Ho Chi Minh City, Vietnam., Le Minh NH; GSK, Ho Chi Minh City, Vietnam. minh.l.nguyen-hoan@gsk.com.
المصدر: Infectious diseases and therapy [Infect Dis Ther] 2024 Mar; Vol. 13 (3), pp. 423-437. Date of Electronic Publication: 2024 Mar 02.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2014- : [Auckland] Adis
Original Publication: [London] : Springer Healthcare
مستخلص: An advisory board meeting was held with experts in Vietnam (Hanoi, August 2022), to review the evidence on invasive meningococcal disease (IMD) epidemiology, clinical management, and meningococcal vaccines to reach a consensus on recommendations for meningococcal vaccination in Vietnam. IMD is a severe disease, with the highest burden in infants and children. IMD presents as meningitis and/or meningococcemia and can progress extremely rapidly. Almost 90% of deaths in children occur within the first 24 h, and disabling sequelae (e.g., limb amputations and neurological damage) occur in up to 20% of survivors. IMD patients are often hospitalized late, due to mild and nonspecific early symptoms and misdiagnosis. Difficulties related to diagnosis and antibiotic misuse mean that the number of reported IMD cases in Vietnam is likely to be underestimated. Serogroup B IMD is predominant in many regions of the world, including Vietnam, where 82% of IMD cases were due to serogroup B (surveillance data from 2012 to 2021). Four component meningococcal B vaccine (4CMenB) is used in many countries (and is part of the pediatric National Immunization Program in 13 countries), with infant vaccination starting from two months of age, and a 2 + 1 dosing schedule. Experts recommend 4CMenB vaccination as soon as possible in Vietnam, starting from two months of age, with a 2 + 1 dosing schedule, and at least completing one dose before 6 months of age.
(© 2024. The Author(s).)
References: Hum Vaccin Immunother. 2022 Nov 30;18(6):2110759. (PMID: 36084311)
J Infect. 2018 Mar;76(3):258-269. (PMID: 29253560)
mSphere. 2020 Mar 25;5(2):. (PMID: 32213620)
PLoS One. 2019 Mar 13;14(3):e0212922. (PMID: 30865671)
Euro Surveill. 2018 Apr;23(17):. (PMID: 29717697)
Vaccine. 2019 Jul 18;37(31):4243-4245. (PMID: 31239214)
Hum Vaccin Immunother. 2016 Nov;12(11):2940-2945. (PMID: 27454468)
Popul Health Metr. 2013 Sep 10;11(1):17. (PMID: 24016339)
Clin Infect Dis. 2021 Jul 1;73(1):e233-e237. (PMID: 33587122)
Vaccine. 2016 Feb 10;34(7):875-80. (PMID: 26686570)
N Engl J Med. 2020 Jan 23;382(4):318-327. (PMID: 31971677)
J Exp Med. 2002 Jun 3;195(11):1445-54. (PMID: 12045242)
BMC Infect Dis. 2012 Nov 19;12:310. (PMID: 23164061)
J Infect. 2020 Nov;81(5):698-711. (PMID: 32730999)
J Immunol. 2006 Jul 1;177(1):501-10. (PMID: 16785547)
Vaccine. 2021 Jun 2;39(24):3296-3303. (PMID: 33962840)
Vaccine. 2020 Jul 6;38(32):4935-4939. (PMID: 32536544)
Science. 2000 Mar 10;287(5459):1809-15. (PMID: 10710307)
Lancet Infect Dis. 2010 Feb;10(2):112-24. (PMID: 20113980)
Hum Vaccin Immunother. 2014;10(7):1993-2004. (PMID: 25424809)
Clin Vaccine Immunol. 2006 Apr;13(4):486-91. (PMID: 16603616)
Hum Vaccin Immunother. 2023 Dec 31;19(1):2172922. (PMID: 36951161)
Expert Rev Vaccines. 2022 Mar;21(3):325-335. (PMID: 35068299)
J Adolesc Health. 2016 Aug;59(2 Suppl):S12-20. (PMID: 27449145)
Vaccines (Basel). 2020 Aug 22;8(3):. (PMID: 32842669)
J Immunol. 1987 Jun 15;138(12):4402-7. (PMID: 3108388)
Hum Vaccin Immunother. 2014;10(9):2706-12. (PMID: 25483487)
J Infect. 2022 Mar;84(3):289-296. (PMID: 34838594)
Vaccine. 2012 May 21;30(24):3710-6. (PMID: 22429756)
MMWR Morb Mortal Wkly Rep. 2016 May 27;65(20):520-1. (PMID: 27227576)
Euro Surveill. 2018 Jul;23(28):. (PMID: 30017022)
Vaccine. 2020 Jun 26;38(31):4816-4819. (PMID: 32482458)
Vaccine. 2020 Aug 18;38(37):5914-5922. (PMID: 32712083)
N Engl J Med. 2020 Jan 23;382(4):309-317. (PMID: 31971676)
Epidemiol Infect. 2011 Jul;139(7):967-85. (PMID: 21492496)
Lancet Child Adolesc Health. 2018 Jun;2(6):395-403. (PMID: 30169281)
Lancet. 2013 Mar 9;381(9869):825-35. (PMID: 23324563)
Vaccine. 2018 Dec 18;36(52):8039-8046. (PMID: 30467063)
JAMA. 2020 Dec 1;324(21):2187-2194. (PMID: 33258889)
فهرسة مساهمة: Keywords: 4CMenB; Infant; Invasive meningococcal disease; Vaccination; Vietnam
تواريخ الأحداث: Date Created: 20240302 Latest Revision: 20240329
رمز التحديث: 20240329
مُعرف محوري في PubMed: PMC10965853
DOI: 10.1007/s40121-023-00905-y
PMID: 38430327
قاعدة البيانات: MEDLINE
الوصف
تدمد:2193-8229
DOI:10.1007/s40121-023-00905-y